Published in

Nature Research, Nature Microbiology, 9(7), p. 1490-1500, 2022

DOI: 10.1038/s41564-022-01191-z

Links

Tools

Export citation

Search in Google Scholar

Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil

Journal article published in 2022 by Marta Giovanetti, Svetoslav Nanev Slavov, Vagner Fonseca ORCID, Eduan Wilkinson ORCID, Houriiyah Tegally, José Salvatore Leister Patané, Vincent Louis Viala ORCID, Emmanuel James San ORCID, Evandra Strazza Rodrigues, Elaine Vieira Santos, Flavia Aburjaile ORCID, Joilson Xavier ORCID, Hegger Fritsch, Talita Emile Ribeiro Adelino ORCID, Felicidade Pereira and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractThe high numbers of COVID-19 cases and deaths in Brazil have made Latin America an epicentre of the pandemic. SARS-CoV-2 established sustained transmission in Brazil early in the pandemic, but important gaps remain in our understanding of virus transmission dynamics at a national scale. We use 17,135 near-complete genomes sampled from 27 Brazilian states and bordering country Paraguay. From March to November 2020, we detected co-circulation of multiple viral lineages that were linked to multiple importations (predominantly from Europe). After November 2020, we detected large, local transmission clusters within the country. In the absence of effective restriction measures, the epidemic progressed, and in January 2021 there was emergence and onward spread, both within and abroad, of variants of concern and variants under monitoring, including Gamma (P.1) and Zeta (P.2). We also characterized a genomic overview of the epidemic in Paraguay and detected evidence of importation of SARS-CoV-2 ancestor lineages and variants of concern from Brazil. Our findings show that genomic surveillance in Brazil enabled assessment of the real-time spread of emerging SARS-CoV-2 variants.